Your browser is no longer supported. Please, upgrade your browser.
Gritstone bio, Inc.
Index- P/E- EPS (ttm)-1.73 Insider Own3.77% Shs Outstand49.43M Perf Week15.63%
Market Cap644.23M Forward P/E- EPS next Y-2.22 Insider Trans-0.27% Shs Float47.58M Perf Month55.99%
Income-70.40M PEG- EPS next Q-0.53 Inst Own71.00% Short Float13.29% Perf Quarter36.77%
Sales44.80M P/S14.38 EPS this Y1.00% Inst Trans2.40% Short Ratio8.49 Perf Half Y1.27%
Book/sh3.62 P/B3.74 EPS next Y-74.80% ROA-34.60% Target Price- Perf Year313.44%
Cash/sh3.60 P/C3.76 EPS next 5Y- ROE-45.70% 52W Range2.54 - 35.20 Perf YTD243.65%
Dividend- P/FCF- EPS past 5Y- ROI-63.60% 52W High-61.53% Beta-
Dividend %- Quick Ratio8.20 Sales past 5Y- Gross Margin- 52W Low434.12% ATR0.90
Employees181 Current Ratio8.20 Sales Q/Q460.00% Oper. Margin- RSI (14)76.12 Volatility9.41% 8.59%
OptionableYes Debt/Eq0.00 EPS Q/Q26.80% Profit Margin- Rel Volume1.74 Prev Close13.54
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume745.24K Price13.54
Recom2.00 SMA2031.92% SMA5055.86% SMA20037.83% Volume0 Change0.00%
Jan-20-21Downgrade Robert W. Baird Outperform → Underperform $8
Jul-26-19Initiated Robert W. Baird Outperform $17
Mar-15-19Initiated Raymond James Outperform
Mar-07-19Initiated H.C. Wainwright Buy $17
Oct-23-18Initiated Goldman Neutral $18
Oct-23-18Initiated BTIG Research Buy $26
Sep-17-21 07:02AM  
Sep-16-21 04:01PM  
Sep-09-21 04:05PM  
Sep-07-21 04:00PM  
Aug-17-21 07:00AM  
Aug-16-21 04:00PM  
Aug-11-21 07:00AM  
Aug-05-21 04:00PM  
Jul-27-21 02:51AM  
Jul-15-21 04:00PM  
Jun-23-21 08:00AM  
Jun-17-21 08:00AM  
Jun-07-21 08:00AM  
Jun-01-21 08:00AM  
May-28-21 03:36AM  
May-24-21 04:00PM  
May-06-21 10:15AM  
May-03-21 08:00AM  
Mar-29-21 07:00AM  
Mar-15-21 06:00AM  
Mar-13-21 06:56AM  
Mar-11-21 10:15AM  
Mar-08-21 08:00AM  
Mar-03-21 12:30PM  
Mar-02-21 08:00AM  
Feb-11-21 06:55AM  
Feb-01-21 04:21PM  
Jan-27-21 08:19AM  
Jan-23-21 06:14AM  
Jan-21-21 08:16AM  
Jan-20-21 07:33PM  
Jan-19-21 03:27PM  
Jan-11-21 08:00AM  
Dec-28-20 08:00AM  
Dec-23-20 08:33AM  
Dec-04-20 10:15AM  
Nov-05-20 09:01AM  
Nov-02-20 08:00AM  
Sep-21-20 09:27AM  
Sep-15-20 08:00AM  
Sep-08-20 08:00AM  
Aug-06-20 05:19PM  
Aug-05-20 10:25AM  
Aug-03-20 12:31PM  
Jul-22-20 02:28PM  
Jun-24-20 08:00AM  
Jun-14-20 08:59PM  
Jun-10-20 08:00AM  
Jun-04-20 08:00AM  
May-22-20 09:15AM  
May-10-20 10:14AM  
May-07-20 11:15AM  
May-01-20 08:00AM  
Apr-06-20 08:00AM  
Mar-13-20 08:30AM  
Mar-11-20 10:25AM  
Feb-25-20 04:00PM  
Jan-08-20 04:00PM  
Jan-01-20 11:27AM  
Dec-16-19 07:36AM  
Dec-12-19 07:38AM  
Dec-09-19 08:00AM  
Nov-26-19 08:00AM  
Nov-12-19 09:01AM  
Nov-06-19 10:30AM  
Nov-05-19 08:05AM  
Oct-31-19 08:00AM  
Oct-07-19 08:00AM  
Sep-27-19 08:22AM  
Sep-26-19 08:00AM  
Sep-12-19 08:00AM  
Aug-14-19 03:40PM  
Aug-12-19 09:01AM  
Jul-08-19 08:00AM  
Jun-05-19 08:00AM  
Jun-03-19 11:00AM  
May-30-19 08:00AM  
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing tumor-specific cancer immunotherapies to fight various cancer types and infectious diseases. Its lead product candidate is GRANITE, which is in Phase I/II clinical trial for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder and microsatellite stable, and colorectal cancers. The company is also developing SLATE, an off-the-shelf immunotherapy candidate for the treatment of common solid tumors, including metastatic non-small cell lung cancer, colorectal cancer, pancreatic cancer, and other mutation-positive tumors. Gritstone Oncology, Inc. has a strategic collaboration with bluebird bio, Inc. The company was formerly known as Gritstone Oncology, Inc. and changed its name to Gritstone bio, Inc. in May 2021. Gritstone bio, Inc. was founded in 2015 and is headquartered in Emeryville, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Jones ErinSee RemarksSep 08Option Exercise0.342,00069022,000Sep 10 04:19 PM
Jones ErinSee RemarksSep 08Sale11.372,00022,74820,000Sep 10 04:19 PM
Rousseau RaphaelSee RemarksMay 27Option Exercise0.762,9002,2012,900Jun 03 06:34 PM
Rousseau RaphaelSee RemarksMay 27Sale9.002,90026,1120Jun 03 06:34 PM
Yelensky RomanSee RemarksMar 08Option Exercise0.7650,72438,500183,948Apr 16 05:13 PM
Rousseau RaphaelSee RemarksJan 20Option Exercise0.7610,0007,60010,000Jan 21 05:11 PM
Rousseau RaphaelSee RemarksJan 20Sale25.0710,000250,7050Jan 21 05:11 PM
Rousseau RaphaelSee RemarksJan 19Option Exercise0.7620,00015,20020,000Jan 21 05:11 PM
Rousseau RaphaelSee RemarksJan 19Sale17.5320,000350,5640Jan 21 05:11 PM
Yelensky RomanSee RemarksJan 19Sale22.1010,000221,029133,224Jan 21 05:06 PM
Woiwode ThomasDirectorDec 30Buy3.711,347,7095,000,0001,347,709Jan 04 06:02 PM